T o maintain high energy requirements for contractile function, the heart requires an uninterrupted delivery of oxygen and substrates that are oxidized to promote ATP synthesis. ATP consumption primarily fuels sarcomere contraction and ionic pumps that maintain membrane potential.
ATP generation in cardiomyocytes. FAs derived from circulating triglyceride-rich lipoproteins and albumin-bound nonesterified FAs are oxidized in the mitochondrial matrix via β-oxidation, whereas pyruvate derived from glucose and lactate is oxidized by the pyruvate dehydrogenase complex, localized within the inner mitochondrial membrane. Acetyl-coenzyme A (CoA) formed from FAs and pyruvate is oxidized within the mitochondrial matrix by the citric acid cycle. Healthy adult cardiomyocytes preferentially use FAs as an energy substrate. [2] [3] [4] However, energy substrate usage is flexible in normal hearts and varies to adapt to physiological or pathological stresses. 5 
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Diabetes mellitus and insulin resistance are the most common metabolic disorders in the world. Cardiovascular complications are the main cause of death from diabetes mellitus, given the high prevalence of comorbid risk factors, such as coronary artery disease. In addition, diabetes mellitus increases the risk for heart failure by mechanisms that may be independent of underlying myocardial ischemia or hypertension. 6 This increased vulnerability termed diabetic cardiomyopathy has a complex pathophysiology that includes altered myocardial substrate utilization. 7, 8 An important characteristic of the metabolic abnormality in diabetic hearts is metabolic inflexibility, characterized by reduced glucose utilization and increased FA utilization. An imbalance between substrate uptake and utilization may lead to the accumulation of toxic metabolic intermediates. 9 Studies by us and others reveal that, in addition to altered substrate utilization, diabetes mellitus or myocardial insulin resistance impairs mitochondrial bioenergetics characterized by decreased oxidative capacity, increased reactive oxygen species (ROS) generation and mitochondrial uncoupling. [10] [11] [12] It is likely that mitochondrial dysfunction is multifactorial, although the relative contributions of increased lipid uptake versus changes in insulin signaling are incompletely understood.
To understand the mechanisms by which increased cardiac lipid uptake could alter mitochondrial function, we investigated mice with cardiomyocyte-restricted low-level overexpression of ACSL1 (long-chain acyl-CoA synthetase 1) in which myocardial palmitate biodistribution was moderately increased (2-fold). 13 In this murine model, the modest increase in FA uptake dramatically remodeled the mitochondrial network, leading to the accumulation of elongated mitochondria with reduced diameter in cardiomyocytes. Similar changes, appearing on 2-dimensional (2D) microscopy as numerous fragmented mitochondria, were recapitulated in neonatal rat ventricular cardiomyocytes (NRVCs) and L6 myotubes after short-term exposure Nonstandard Abbreviations and Acronyms 2D 2 dimensional 
Novelty and Significance
What Is Known?
• Obesity and diabetes mellitus induce myocardial lipotoxicity that may reduce cardiac function.
• Cardiac lipotoxicity is associated with mitochondrial dysfunction including decreased oxidative phosphorylation via incompletely understood mechanisms.
What New Information Does This Article Contribute?
• Myocardial lipid overload by saturated fatty acids transiently increases mitochondrial respiration, polarization, and reactive oxygen species production.
• Fatty acid-induced mitochondrial reactive oxygen species overproduction induces post-translational modifications of mitochondrial fusion/ fission regulatory proteins that precipitate increased mitochondrial fission.
• Three-dimensional electron tomography revealed that lipid overload in postnatal hearts induces reactive oxygen species-mediated fragmentation of the mitochondrial network, characterized by narrow tortuous and tubular morphology.
Obesity, insulin resistance, and diabetes mellitus are associated with increased fatty acid utilization and reduced glucose utilization. One proposed mechanism for cardiac dysfunction called lipotoxicity is excess intracellular lipid accumulation secondary to a mismatch between lipid supply and utilization. In this study, using a mouse model with increased myocardial lipid uptake, we demonstrate that myocardial lipid overload induces mitochondrial reactive oxygen species production, which alters the activity of DRP1 (dynamin-related protein 1) and OPA1 (optic atrophy 1), leading to fragmentation of the mitochondrial network characterized by a narrow tubular morphology. Thus, dysregulation of mitochondrial dynamics after lipid overload may represent an important mechanism contributing to mitochondrial and contractile dysfunction in lipotoxic cardiomyopathies.
to the long-chain FA palmitate. Mechanistically, these changes in mitochondrial morphology reflected changes in mitochondrial dynamics that were mediated via ROS-induced posttranslational modification of mitochondrial proteins, AKAP121 (A-kinase anchor protein 121), DRP1 (dynamin-related protein 1), and OPA1 (optic atrophy 1). Thus, lipid overload leads to dysregulation of mitochondrial dynamics, which may impair mitochondrial bioenergetics in diabetic cardiomyopathy.
Methods
The authors declare that all supporting data are available within the article (and its online supplementary files in the Online Data Supplement). Detailed methods can be found in the Online Data Supplement.
Results

Increased FA Uptake Elevates Myocardial Ceramide and Diacylglycerol Content and Induces Cardiac Hypertrophy and Modest Systolic Dysfunction
To investigate the consequences of persistent lipid overload in the heart, we examined mice with low-level overexpression of ACSL1 driven by the cardiomyocyte-specific α-MHC (myosin heavy chain) promoter (Acsl1 transgenic [ACStg] mice). Because our goal was to examine mitochondrial adaptations before the onset of lipotoxic cardiomyopathy, we studied the line with the lowest level of ACSL1 overexpression, which does not develop overt heart failure until animals are 4 months old. 13 Transgene expression was examined through development, and ACSL1 protein was undetectable by Western blot in both wild-type (WT) and ACStg mice at birth (P0 [postnatal day zero]) despite ACSL1 mRNA expression being 13-fold greater in ACStg neonates compared with WT neonates ( Figure 1A and 1B). Increased ACSL1 protein in ACStg hearts was observed after P7 ( Figure 1A ). Palmitate biodistribution measured by in vivo positron emission tomography at 12 weeks of age was increased 2-fold, indicating increased cardiac FA uptake in ACStg hearts ( Figure 1C ). At this time point, there was no increase of myocardial triglyceride content in ACStg hearts under random fed conditions ( Figure 1D ). However, myocardial ceramide and diacylglycerol content were significantly increased in ACStg hearts ( Figure 1E and 1F). Consistent with the previous report, this moderate increase of lipid uptake induced a modest increase in ventricular weight/body weight ratio and ventricular wall thickness (interventricular septum) on the basis of cardiomyocyte hypertrophy in ACStg hearts (Figure 1G through 1I; Online Figure I ). 13 Although there was no statistically discernable difference in left ventricular end-diastolic volume and left ventricular ejection fraction measured by echocardiography ( Figure 1J and 1K), cardiac catheterization revealed a significant reduction in arterial blood pressure in ACStg mice accompanied by decreased max dP/dt and min dP/dt by the age of 24 weeks ( Figure 1L through 1N) . Furthermore, B-type natriuretic peptide expression and Acta1 (α-skeletal muscle actin) expression were modestly increased in ACStg hearts by 2-fold (B-type natriuretic peptide) and 1.3-fold (Acta1) at the age of 12 weeks ( Figure 1O ). Taken together, a 2-fold increase of lipid uptake induces modest cardiac hypertrophy with preserved systolic function at the age of 12 weeks but impairs systolic function at the age of 24 weeks.
Increased Respiration and ROS Production in Isolated Mitochondria From ACStg Hearts
In ACStg mice, oxygen consumption rates (OCRs) and ATP synthesis rates in isolated mitochondria incubated with palmitoyl-carnitine as a substrate were increased at 12 weeks of age, but were unchanged at 24 weeks of age relative to WT controls (Figure 2A and 2B) . In contrast, OCRs were not impaired with pyruvate or glutamate as substrates at 12 and 24 weeks of age, respectively ( Figure 2C and 2D ). In addition, in-gel activities (in blue-native PAGE) of oxidative phosphorylation complexes I and IV were unchanged, but complex V activity was increased at 12 weeks of age in ACStg hearts ( Figure 2E through 2G) . Mitochondrial superoxide production (measured as H 2 O 2 release from mitochondria) was increased 2-fold in ACStg heart mitochondria exposed to succinate or palmitoyl-carnitine as a substrate and was completely inhibited by the addition of rotenone ( Figure 2H ). Increased ROS was not observed when glutamate was used as a substrate (Online Figure IIA) , suggesting that ROS production derives from reducing equivalents that are oxidized by complex II. Oxidation of 2′,7′-dichlorofluorescein diacetate was increased in whole-cell extracts of ACStg hearts ( Figure 2I ). Moreover, increased mitochondrial 4HNE (4-hydroxy-2-nonenal) adducts in ACStg mitochondrial proteins, a highly toxic aldehyde byproduct of lipid peroxidation caused by ROS production, also support increased mitochondrial ROS production ( Figure 2J ). However, activity of mitochondrial aconitase was not reduced, suggesting that there was no increase in oxidative stress in the mitochondrial matrix of ACStg hearts, potentially the result of increased superoxide dismutase 2 (SOD2) content ( Figure 2K ; Online Figure IIB) . Thus, short-term low-level lipid overload does not initially impair mitochondrial oxidative capacity in the murine heart despite increasing ROS generation.
Postnatal Increase in Mitochondrial CrossSectional Area Is Attenuated in Lipid-Overloaded Cardiomyocytes
We next investigated mitochondrial morphology. During the early postnatal period, cardiomyocytes dynamically change their structure and function adapting to the increased workload and oxygen consumption that parallels the switch of substrate utilization from glycolysis to mitochondrial FA oxidation. 3 Mitochondrial morphology also changes, and volume density increases as they become larger and more ovoid in shape.
14 Two-dimensional electron microscopy revealed that mitochondrial dimension in WT hearts increased 2-fold within the first 3 weeks after birth before plateauing ( Figure 3A ; Online Figure IIIA ). This postnatal mitochondrial enlargement was absent in ACStg mice ( Figure 3A ; Online Figure IIIA ). In contrast, mitochondrial volume density was significantly increased in ACStg hearts (Figure 3A and 3B; Online Figure IIIB and IIIC), based on the appearance of accumulated small mitochondria. To evaluate mitochondrial morphology more precisely, we performed 3D transmission electron microscopic tomography at the age of 8 weeks. Three-dimensional mitochondrial images revealed the presence of narrow but elongated mitochondria whose tortuous shapes crossed individual sectioning planes more than once ( Figure 3B and 3C ). This is associated with an increase in number of cytosol-mitochondrial membrane transitions on any projection between the M-lines of neighboring myofilament bundles ( Figure 3D ). The short-axis diameter of mitochondria was significantly reduced in ACStg hearts by 60% ( Figure 3E ). Taken together, perinatal lipid overload significantly alters age-dependent structural mitochondrial remodeling, characterized by a reduction in minimum diameter and morphological changes that are consistent with fragmentation of the mitochondrial network.
These morphological changes could also reflect increased biogenesis or altered dynamics of the mitochondrial network. To address this, we examined mRNA expression levels of PGC-1α/β (peroxisome proliferator-activated receptor γ coactivators 1 α/β) and their targets but found no evidence for increased mitochondrial biogenesis signaling ( Figure 3F ). Thus, we hypothesized that lipid overload may alter signaling pathways that regulate mitochondrial dynamics.
Mitochondrial dynamics is regulated by the activity of the dynamin superfamily of large GTPases, specifically Mfn (mitofusin) 1 and 2, Opa1, and DRP1. 15, 16 Mitochondrial fusion is mediated by OPA1 and Mfn1/2 which reside on mitochondrial inner and outer membranes, respectively. Fission is controlled by the cytosolic protein DRP1 that translocates from the cytosol to mitochondrial membranes after post-translational modifications to interact with the outer mitochondrial membrane protein Fis1 (mitochondrial fission 1). We determined the protein levels of these mitochondrial fusion and fission proteins and DRP1 phosphorylation during postnatal cardiac growth. Western blot analysis of whole-heart lysates from WT mice revealed that DRP1 phosphorylation dramatically changed during the first 3 weeks of life ( Figure 3G ; Online Figure IVA) . Consistent with increased postnatal mitochondrial dimensions (fusion), DRP1 phosphorylation at S616, which activates DRP1-mediated mitochondrial fission, declined with age. In contrast, DRP1 phosphorylation at S637, which induces mitochondrial fusion by inhibiting DRP1-mediated mitochondrial fission, increased over time ( Figure 3G ; Online Figure IVA ). This developmental increase in DRP1 S637 phosphorylation was not observed in ACStg mice ( Figure 3H ; Online Figure IVB ). These data suggest that cardiac lipid overload impairs postnatal mitochondrial remodeling by modulating DRP1 phosphorylation.
Lipid Overload Alters Ubiquitin/ProteasomeMediated AKAP121 Degradation and OPA1 Proteolysis
Protein kinase A-mediated DRP1 phosphorylation at S637 inhibits DRP1 localization to mitochondria and subsequent mitochondrial fission. 17 The mitochondrial localization of protein kinase A and its ability to phosphorylate DRP1 is mediated by ubiquitin/proteasome-mediated degradation of AKAP121 (A-kinase anchor protein 121), which is a mitochondrial outer membrane scaffold protein. [18] [19] [20] We therefore examined whether AKAP121 protein content might be decreased in ACStg hearts. In 12-week-old ACStg mouse hearts, Western blotting revealed that DRP1 phosphorylation at S637 was significantly reduced and phosphorylation at S616 increased ( Figure 4A through 4C ). In addition, AKAP121 expression was also significantly decreased in ACStg hearts relative to WT ( Figure 4A and 4D) , which was not related to any difference in AKAP121 mRNA expression ( Figure 4E ). Therefore, we tested whether post-translational regulation by the ubiquitin/proteasome system might increase AKAP121 degradation in the face of lipid overload. WT or ACStg mice were injected intraperitoneally with MG132 (carbobenzoxyLeu-Leu-leucinal) or DMSO and whole-heart homogenates were subjected to Western blot analysis. The proteasome inhibitor MG132 blocked the reduction of AKAP121 protein content in ACStg mice, suggesting that AKAP121 is degraded by the ubiquitin/proteasome system pathway in response to lipid overload ( Figure 4F ). AKAP121 is a target of the ubiquitin ligase Siah2 (seven in absentia homolog 2) in the context of hypoxia. 20 However, Siah2 mRNA expression was not increased in ACStg hearts ( Figure 4G ). Taken together, lipid overload altered DRP1 phosphorylation by enhancing AKAP121 degradation which may be independent of the hypoxia-stimulated pathway.
We also examined whether the mitochondrial fusion protein, OPA1, could be affected by lipid overload. There are at least 8 mRNA variants of OPA1 as a result of alternative splicing. 21 Variants 1 and 7 are dominant variants in mammalian cells. In response to mitochondrial depolarization, OPA1 also undergoes proteolytic cleavage which impairs its ability to induce mitochondrial fusion. 22 Western blot analysis of heart mitochondrial protein showed 5 bands of OPA1, 2 fusion-competent long isoforms and the 3 fusion-incompetent short isoforms generated by the proteolytic processing of the 2 long isoforms ( Figure 4H ). Consistent with enhanced mitochondrial network fragmentation in ACStg hearts, the ratio of short form to long form was increased by 1.7-fold in ACStg hearts ( Figure 4H and 4I) . Thus, these data support the hypothesis that mitochondrial dynamics shifts toward enhanced mitochondrial fission by at least 2 distinct mechanisms. Figure IVA) . Each sample at 0 d, 1 wk, and 3 wk was isolated >3× and immunoblotted separately, and each sample at day 1, 2 wk, and 8 wk was repeated twice. A representative Western blot is shown. H, Western blot of whole-heart lysates from WT and ACStg mice probed with antibodies as indicated and harvested at the ages shown (Online Figure IVB) . All data are mean±SEM. Each sample at day 0, 1 wk, and 3 wk was isolated >3× and immunoblotted separately, and each sample at 2 and 8 wk was repeated twice. A representative Western blot is shown. COXIV indicates cytochrome c oxidase subunit IV; Cytb, cytochrome b; DRP1, dynamin-related protein 1; Mfn, mitofusin; Ndufa9, NADH dehydrogenase ubiquinone 1 alpha subcomplex subunit 9; Ndufv1, NADH dehydrogenase ubiquinone flavoprotein 1; NRF1, nuclear respiratory factor 1; OPA1, optic atrophy 1; PGC-1a, peroxisome proliferator receptor gamma co-activator 1 alpha; PGC-1b, peroxisome proliferator receptor gamma co-activator 1 beta; and TFAm, mitochondrial transcription factor A. Whole-heart lysates were subjected to Western blot analysis (A) and densitometric quantification of DRP1pS616 (B), DRP1pS637 (C), and AKAP121 (D), n=4. **P<0.01, *P<0.05. E, AKAP121 mRNA expression of 12-wkold wild-type (WT) and ACStg mice was determined by quantitative RT-PCR, n=4. F, AKAP121 degradation is mediated by the ubiquitin/ proteasome pathway in ACStg hearts. WT or ACStg mice were injected intraperitoneally twice with DMSO or MG132 (18 and 6 h before euthanasia). Whole-heart lysates were subjected to Western blot analysis. G, Siah2 gene expression in 12-wk-old WT and ACStg mouse hearts was determined by RT-PCR. Values are normalized to GAPDH expression. n=4. H, I, Increased OPA1 cleavage in ACStg hearts. Mitochondrial fractions were prepared from 12-wk-old WT or ACStg hearts and subjected to Western blot analysis. Each lane shows the sample from different animals. The top 2 bands correspond to noncleaved isoforms of OPA1 (long form), and the bottom 3 bands correspond to cleaved isoforms of OPA1 (short form; H), quantitative densitometric analysis of OPA1 isoforms (I), n=4. *P<0.05 vs WT. All data are mean±SEM. N.S. indicates not significant.
Effect of
Oxygen consumption of lipid-treated NRVCs was determined with the Seahorse XF24 flux analyzer. Although short exposure to palmitate (<4 hours) increased mitochondrial OCRs in NRVCs, continued exposure (>8 hours) reduced OCR (Figure 5A and 5B; Online Figure VA and VB). In contrast, oleate treatment did not alter mitochondrial OCR ( Figure 5A ). To confirm that this increase of OCR is coupled to mitochondrial oxidative phosphorylation and ATP synthesis, we examined Figure 5 . Mitochondrial metabolism and reactive oxygen species (ROS) production in rat neonatal cardiomyocytes after increasing duration of free fatty acids exposure. A, Basal oxygen consumption rate (OCR; assayed by the Seahorse XF24 system) in neonatal rat ventricular cardiomyocytes (NRVCs) incubated with BSA(bovine serum albumin) alone, palmitate-BSA (500 μmol/L) or oleate-BSA (500 μmol/L). **P<0.01. B, Time course analysis of OCR of NRVCs treated with palmitate-BSA. Increased basal OCR after short-term exposure to palmitate (3 h) and reduced basal OCR after long-term exposure (15 h) of palmitate. **P<0.01 (Online Figure V) . C, Time course analysis of ATP content in NRVCs after palmitate or oleate treatment. **P<0.01 vs BSA, #P<0.05, ##P<0.01. D, Time course analysis of mitochondrial polarization (membrane potential) after palmitate or oleate treatment. Cardiomyocytes were stained with TMRM (tetramethylrhodamine, methyl ester) and Hoechst at indicated times and fluorescence intensity was assayed with a plate reader. The ratio of TMRM/Hoechst fluorescence is shown. n=4, *P<0.05 vs BSA, #P<0.05. E, Western blot for 4HNE (4-hydroxy-2-nonenal) protein adducts in NRVCs after palmitate or oleate treatment. F, G, CellROX green staining in NRVCs after palmitate treatment. CellROX Green is a DNA dye, and on oxidation, it binds to DNA. Representative confocal image (F) and fluorescence intensity were quantified (G). **P<0.01 vs BSA. All data are mean±SEM. Scale bars indicate 20 μm. Figure 6 . DRP1 (dynamin-related protein 1) mediates mitochondrial fission after lipid overload. A, Rat neonatal cardiomyocytes were stimulated with growth medium with or without 500 μmol/L palmitate or oleate. Twelve hours after stimulation, cells were fixed with 4% paraformaldehyde and immunostained with α-actinin (green), Tom20 (translocase of outer membrane 20kDa, red), and DAPI (blue). Scale bars indicate 20 μm. B, Quantification of mitochondrial fragmentation presented in A. More than 100 cells were counted to determine the percentage (%) of cells with fragmented mitochondria. n=3, **P<0.01. C, Increased phosphorylation of DRP1 at Ser616 after palmitate treatment. Neonatal rat ventricular cardiomyocytes (NRVCs) were treated in growth medium with 500 μmol/L palmitate, and cell lysates were harvested at the indicated times in hour. D, NRVCs were treated in growth medium with or without 500 μmol/L palmitate and subjected to immunohistochemistry for DRP1 (green) and Tom20 (red). Note that DRP1 is colocalized with Tom20 after palmitate treatment. Scale bars indicate 20 μm. E, NRVCs were infected with AdGFP (adenovirus encoding GFP) or Ad DRP1K38E and were treated in growth medium with 500 μmol/L palmitate. NRVCs were subjected to immunohistochemistry for α-actinin (green) and Tom20 (red; Online Figure VIIA time course changes of mitochondrial membrane potential and ATP content after palmitate treatment. Consistent with OCR, palmitate treatment initially increased mitochondrial polarization and ATP content, but these parameters declined after continued incubation for >12 hours ( Figure 5C and 5D) . We also examined ROS production of cardiomyocytes after palmitate or oleate treatment. As expected, Western blotting of 4HNE revealed that ROS production was increased after palmitate treatment ( Figure 5E ). CellROX Green (ROS probe) also accumulated in the nucleus after 12 hours of palmitate treatment ( Figure 5F and 5G). In contrast, oleate treatment did not increase 4HNE accumulation ( Figure 5E ). Taken together, palmitate supplementation initially accelerates mitochondrial respiration that is coupled to ATP synthesis. However, continued exposure to palmitate induces mitochondrial respiratory failure, potentially on the basis of ROS-induced injury. Figure VIA) . Interestingly, these morphological changes were not observed in oleate-treated cardiomyocytes ( Figure 6A and 6B) . We examined DRP1 phosphorylation profiles in NRVCs after palmitate treatment. Similar to P0 hearts ( Figure 3G and 3H) , we detected no phosphorylation at S637 in isolated NRVCs throughout the time course. Instead, palmitate treatment increased DRP1 phosphorylation at S616 in NRVCs ( Figure 6C ). Immunohistochemistry revealed DRP1 translocation from the cytosol to mitochondria in response to palmitate treatment ( Figure 6D ). To validate that DRP1 mediates mitochondrial network fragmentation in lipid overload, we examined the effect of DRP1K38E, a dominant negative mutant of DRP1.
25 DRP1K38E overexpression prevented palmitate-induced mitochondrial network fragmentation in NRVCs ( Figure 6E ; Online Figure VIIA) . Furthermore, the reduced mitochondrial cross-sectional area observed was partially reversed in ACStg mice that lacked 1 DRP1 allele in cardiomyocytes (ACStg DRP1 +/− ; Figure 6F ; Online Figure VIIB through VIIE). Taken together, palmitate exposure shifts mitochondrial dynamics toward fission and away from fusion, in part via a DRP1-mediated mechanism.
Mitochondrial morphology reflects the balance of mitochondrial fusion and fission. To directly evaluate if palmitate exposure inhibits mitochondrial fusion leading to mitochondrial network fragmentation, we cocultured L6 myoblasts expressing either mitoGFP (mitochondrial-green fluorescent protein) or mitoRFP (mitochondrial-red fluorescent protein) and induced cell fusion with polyethylene glycol. L6 myoblasts displayed mitochondrial network fragmentation which was evident after 3 hours of palmitate supplementation ( Figure 7A and 7B). Mitochondrial network fragmentation was further augmented when expression of ACSL1 was increased after retroviral transduction (Online Figure VIB) . After the induction of cell fusion with polyethylene glycol, fusion of GFP and RFPlabeled mitochondria was evident in cells treated with control media when imaged 8 hours after polyethylene glycol-induced cell fusion ( Figure 7C, top) . In contrast, mitochondrial fusion was not observed in the cells incubated with palmitate-supplemented medium ( Figure 7C, middle) . To determine if palmitate pre-exposure permanently impacted mitochondrial fusion in L6 myoblasts, cells were pretreated with palmitate-supplemented medium for 3 hours that disrupted the mitochondrial network and then the medium was replaced with normal growth medium. Mitochondria regained their tubular structure after removal of palmitate, and fusion of GFP and RFP mitochondrial populations was observed, suggesting that palmitate-induced defects in mitochondrial fusion are reversible ( Figure 7C, bottom) .
Contribution of Mitochondrial ROS Generation to FA-Mediated Mitochondrial Fragmentation
In light of our observations of increased lipid-mediated ROS production in vivo and in vitro that correlated with mitochondrial network fragmentation, we tested the hypothesis that elevated mitochondrial ROS production may initiate downstream signaling events to alter mitochondrial dynamics. Because mitochondrial SOD2 mediates superoxide detoxification at a diffusion-limiting rate in the mitochondrial matrix, 26 we examined whether SOD2 overexpression could rescue altered mitochondrial morphology in ACStg hearts. We generated a cardiac-specific double transgenic mouse harboring SOD2 and ACSL1 transgenes (ACS×SOD2 mice). As expected, enhanced superoxide production and increased 4HNE adducts observed in ACStg mitochondria were almost completely rescued by the overexpression of SOD2 (Figure 8A and 8B; Online Figure VIIIA) . Mitochondrial cross-sectional area and apparent number were normalized in ACStg hearts by SOD2 overexpression ( Figure 8C ; Online Figure VIIIB) . Surprisingly, SOD2 overexpressing cardiomyocytes with reduced ROS production demonstrated a 4-fold increase in mitochondrial cross-sectional area estimated from 2D images, suggesting that mitochondrial ROS levels are inversely correlated with mitochondrial dimensions (Figure 8A and 8C) .
Finally, we determined whether altered DRP1 phosphorylation or changes in OPA1 processing in ACStg mice were prevented by SOD2 overexpression. Western blot analysis showed that protein expression of AKAP121 and DRP1 phosphorylation at S637 was increased and DRP1 phosphorylation at S616 was reduced by SOD2 overexpression (Figure 8D and 8E ). In addition, total levels of DRP1 normalized to voltage-dependent anion channel, which were increased in ACStg hearts, were normalized by SOD2 overexpression (Figure 8F and 8H) . Overexpression of ACSL1 enhanced OPA1 proteolysis to specifically increase short isoform-d formation ( Figure 8F 
Discussion
Recent studies have suggested that impaired mitochondrial energetics may contribute to the increased risk of heart failure in type-2 diabetes mellitus. 8 The pathophysiology of mitochondrial dysfunction in diabetes mellitus is complex and may include altered insulin signaling, glucotoxicity, and lipotoxicity. Prior work from our group suggested that impaired myocardial insulin signaling could precipitate mitochondrial dysfunction in the heart. 11 Given the likelihood that lipotoxicity could have distinct effects on mitochondria, the present study was designed to model increased myocardial lipid accumulation to a level that was similar in magnitude to that reported in animal models of obesity and diabetes mellitus. 27 We therefore used mice with cardiomyocyte-specific, low-level overexpression of ACSL1, which gradually developed myocardial dysfunction and recapitulated key observations in neonatal cardiomyocytes that were incubated with palmitate. First, we observed that lipid overload initially enhances mitochondrial respiration coupled to ATP synthesis. However, prolonged lipid overload enhanced mitochondrial ROS generation, which is followed by reduced mitochondrial respiration and ATP synthesis. Second, we observed differential metabolic fates of palmitate and oleate in NRVCs. Our data indicate that increased mitochondrial respiration after palmitate supplementation results in accumulation of mitochondrial ROS and impaired mitochondrial energetics. Conversely, oleate supplementation did not increase mitochondrial respiration or ROS production and did not precipitate mitochondrial impairment. Third, mitochondrial redox status might influence mitochondrial morphology by modulating the post-translational modifications of proteins that regulate mitochondrial dynamics. Lipid overload increased AKAP121 ubiquitination, modulated DRP1 phosphorylation, and altered OPA1 processing. Future studies in models with inducible increases in myocardial lipid uptake will be needed to determine whether these mechanisms also alter mitochondrial dynamics and energetics in adult (postnatal) murine hearts. Prior studies from our laboratory showed altered mitochondrial morphology in db/db diabetic mice or type-1 diabetic Akita mice, which was accompanied by enhanced mitochondrial ROS production. 10, 28 A recent study also revealed that right atrial cardiomyocytes isolated from type-2 diabetic patients exhibit increased mitochondrial ROS production and impaired mitochondrial bioenergetics. 29 Taken together, these observations suggest that the mechanism observed in the present study could be universally applicable to the pathophysiology of mitochondrial dysfunction in lipotoxic cardiomyopathy associated with obesity or diabetes mellitus.
After uptake of FAs in cardiomyocytes, ACSLs immediately catalyze FAs to Acyl-CoA esters, which enter a variety of lipid metabolic pathways such as FA oxidation, TG synthesis/storage, phospholipid metabolism, and de novo ceramide synthesis. Cardiac ACSL1 overexpression in vivo increases mitochondrial ROS production and the content of reactive lipid metabolites. We used a genetic approach to modulate mitochondrial ROS production by overexpressing ACSL1, SOD2, or both and demonstrated that mitochondrial redox status correlates with mitochondrial morphology. In addition, mitochondrial redox status is also associated with processing of mitochondrial proteins, such as OPA1 proteolysis, ubiquitin/proteasome-mediated degradation of AKAP121, and DRP1 phosphorylation at S637. DRP1 phosphorylation at S616, a target site for MAP (mitogen-activated protein) kinases and cyclin-dependent kinase 1, 30-32 also correlated with mitochondrial redox status and was recapitulated by in vitro palmitate treatment of NRVCs. These data are also supported by a recent publication showing that the ROMO1 (ROS modulator 1), a mitochondrial protein, is a redox-sensitive factor that regulates mitochondrial morphology by affecting OPA1 cleavage and oligomerization. 33 A recently described mechanism that may also induce mitochondrial fission is hypoxia. Siah2, a RING finger ubiquitin ligase induced by hypoxia, mediates ubiquitin/proteasome degradation of AKAP121. Subsequent reduction of protein kinase A-dependent inhibitory phosphorylation of DRP1 is an important regulatory pathway for hypoxia-induced mitochondrial fission. 20 In ACStg hearts, we also observed substantial proteasome-mediated degradation of AKAP121, and mitochondrial redox status was correlated with AKAP121 protein levels and DRP1 phosphorylation at S637. However, in contrast to hypoxia, Siah2 mRNA induction was not observed in ACStg hearts ( Figure 4G ), suggesting that an alternative mechanism may link the AKAP121 and DRP1 pathways in cardiac lipid overload.
Our data also reveal that substrate availability and mitochondrial dynamics play important roles in the developmental maturation of mitochondria in the perinatal period. In fetal cardiomyocytes, energy substrate utilization mainly depends on lactate and glucose supplied from the maternal circulation. After birth, energy substrate utilization shifts rapidly from lactate oxidation and glycolysis to FA oxidation in mitochondria, and cardiomyocytes preferentially use FA as an energy source throughout their life. 2, 34 In this process, mitochondria undergo profound remodeling in terms of shape and volume, which is accompanied by an increase in the activities of enzymes required for lipid oxidation, such as long-chain acyl-CoA dehydrogenase, medium-chain acyl-CoA dehydrogenase, carnitine palmitoyl transferase I, and ACSL1. 4, 35 The progressive postnatal increase in mitochondrial diameter was absent in ACStg hearts, which showed a multitude of apparently small mitochondria occupying a larger fractional cell volume than WT. Three-dimensional electron micrograph tomographic reconstructions revealed a narrow, elongated, and tortuous morphology of mitochondria that is principally different from WT and which would be sectioned multiple times in a single plane. Our novel imaging methodology underscores the challenges in estimating mitochondrial size and number from 2D images and adds new insight into the structural adaptations of mitochondria in the heart when signaling pathways that regulate mitochondrial dynamics are perturbed.
The substantial increase of FA availability in the perinatal circulation activates PPARα (peroxisome proliferator-activated receptor-α) that drives FA oxidation in mitochondria. 36, 37 We show here that DRP1 phosphorylation is rapidly modulated during postnatal cardiac development. Furthermore, forced lipid uptake in the early postnatal period alters the developmental changes in DRP1 phosphorylation and prevented physiological and maturation-dependent mitochondrial fusion. An indispensable role of DRP1 in perinatal cardiac development has been recently reported. [38] [39] [40] Taken together, post-translational modifications of DRP1 after birth play an important role in normal perinatal mitochondrial maturation.
Along with the alteration of mitochondrial membrane dynamics, mitochondrial membrane lipid content was also affected in our cardiac lipid overload model. Although the detailed molecular mechanisms involved are incompletely understood, the lipid composition of cristae membrane, specifically cardiolipin and phospholipids, plays an important role in mitochondrial membrane fluidity, cristae structure, and oxidative phosphorylation. 41 Consistent with an elevation of cardiac ceramide and diacylglycerol levels ( Figure 1E and 1F), phospholipid composition and the side chain pattern of cardiolipin were significantly altered in ACStg mitochondrial membranes (Online Figure IXA and IXB) . Interestingly, there was a significant reduction in tetralinoleic (18:2) 4 cardiolipin (Online Figure IXA) . It is widely accepted that tetralinoleic cardiolipin is the fully functional cardiolipin species, and the reduction of tetralinoleic cardiolipin has been associated with diabetes mellitus, heart failure, ischemia-reperfusion injury, all of which are associated with impaired mitochondrial function. 42, 43 These changes are due in part to an important role for cardiolipin in mitochondrial supercomplex formation and cytochrome oxidase activity. 44 Moreover, tetralinoleic cardiolipin is thought to promote more efficient proton flow, and as such the reduction observed in ACStg mice could account in part for the increased ROS generation.
We also addressed the contribution of increased ceramide content in altering mitochondrial morphology in our lipid overload model in vivo and in vitro. Using myriocin, an inhibitor for serine palmitoyltransferase, which catalyzes the first step of de novo ceramide synthesis, we determined that the inhibition of de novo ceramide synthesis exacerbated ROS production in palmitate-treated NRVCs (Online Figure XA through XE) . Furthermore, in vivo inhibition of ceramide synthesis by heterozygous deletion of dihydroceramide desaturase 1, an enzyme that catalyzes de novo ceramide synthesis, failed to reverse the altered mitochondrial network (Online Figure XF) . These data indicate that increased ROS resulting from mitochondrial lipid oxidation likely represents a primary mechanism responsible for augmenting mitochondrial fission in lipid overload and that ceramide accumulation does not contribute to this process.
In summary, we demonstrate here that increased myocardial lipid uptake impairs mitochondrial dynamics by increasing mitochondrial ROS generation, which modulates post-translational modification of OPA1 and DRP1 (Online Figure XI) . We also provide evidence that mitochondrial dynamics is involved in perinatal mitochondrial maturation and forced lipid uptake interferes with that process. These findings add a new dimension to understanding the regulation of mitochondrial morphology and physiology in the heart and its dysregulation by lipid excess.
